Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Cognitive disturbances in neuroleptic therapy.

Cognitive disturbances in neuroleptic therapy. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Cognitive disturbances in neuroleptic therapy. Abstract Text:

    w h straussW H Strauss,e klieserE Klieser,

    Eighteen patients (7 men, 11 women) from one of the centres taking part in a multicentre comparative study of remoxipride and haloperidol in the treatment of acute schizophrenia were investigated separately to study the effect of the two neuroleptic drugs on cognitive abilities. The tests of cognitive ability that were used are standard in West Germany. The results of this study indicate that there could be differences between remoxipride and haloperidol regarding their effects on cognitive abilities--the patients who had been treated for four weeks with remoxipride showed a greater "mental fitness".

    Cognitive disturbances in neuroleptic therapy. Publishing Authors By Initials

    wh straussWH Strauss,e klieserE Klieser,

    For similar disorders of environmental origin: substance-related disorders research abstracts see: disorders of environmental origin: substance-related disorders research

    PUBMED ID PMID:

    MEDLINE DATE:

    Cognitive disturbances in neuroleptic therapy. Journal Published:

    PUBLICATION TYPE: Randomized Controlled Trial

    Journal: Acta psychiatrica Scandinavica. Supplementum

    VOLUME: 358

    Page Numbers: 56-7

    Journal Abbreviation:

    ISSN: 0065-1591

    DAY: 15

    MONTH: 02

    YEAR: 1990

    Cognitive disturbances in neuroleptic therapy. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 370365

    Cognitive disturbances in neuroleptic therapy. Keywords Mesh Terms:

    KEYWORDS: Substance-Related Disorders

    MESH TERMS: etiology

    Chemical & Substance for Abstract: Cognitive disturbances in neuroleptic therapy. Information

    Substance Name: Remoxipride

    Registry Number: 80125-14-0

    Grant and Affiliation Information for Cognitive disturbances in neuroleptic therapy.

    AFFILIATION: Department of Psychiatry, University of Düsseldorf, FRG.

    Country: DENMARK

    DENMARK Research PublicationDENMARK Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Acta Psychiatr Scand Suppl

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Cognitive disturbances in neuroleptic therapy Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News